Neurocrine(NBIX)
$150.57-6.02 (-3.84%)
NBIX
Neurocrine earnings date
$150.57
At close:-6.02 (-3.84%)
Want to see NBIX full AI Analyst Report?
Neurocrine (NBIX) Q4 2022 Earnings Report
1,682 Followers
NBIX Q4 2022 EPS Results
- Actual EPS
- $0.88
- Consensus EPS
- $1.12
- Beat/Miss
- Missed by -$0.24
- One Year Ago EPS
- -$0.08
NBIX Q4 2022 Revenue Results
- Actual Revenue
- $412.00M
- Expected Revenue
- $408.87M
- Beat/Miss
- Beat by +$3.13M
- YoY Revenue Growth
- +32.05%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/06/2023
- Time
- Before Open
- Conference Call
- Monday, February 6, 2023
NBIX Upcoming Earnings
Neurocrine's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
NBIX Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
NBIX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2026 (Q4) | 2.07- | 1.48 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 1.911.96 | 2.04 | -3.92% (-0.08) | |
| Jul 30, 2026 | 2026 (Q2) | 1.651.39 | 1.06 | 31.13% (+0.33) | |
| May 05, 2026 | 2026 (Q1) | 1.221.91 | 0.08 | 2287.50% (+1.83) | |
| Feb 11, 2026 | 2025 (Q4) | 1.801.48 | 1 | 48.00% (+0.48) | |
| Oct 28, 2025 | 2025 (Q3) | 1.592.04 | 1.24 | 64.52% (+0.80) | |
| Jul 30, 2025 | 2025 (Q2) | 0.961.06 | 0.63 | 68.25% (+0.43) | |
| May 05, 2025 | 2025 (Q1) | 0.540.08 | 0.42 | -80.95% (-0.34) | |
| Feb 06, 2025 | 2024 (Q4) | 1.611.00 | 1.44 | -30.56% (-0.44) | |
| Oct 30, 2024 | 2024 (Q3) | 1.491.24 | 0.82 | 51.22% (+0.42) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


